Jonathan Shamash MBChB, MD, MRCP @NHSBartsHealth @NHSEnglandLDN #TesticularCancer #Cancer #Research The Impact Of A SMDT On Decision- Making in Testicular Cancers Testicular 2 Mins Read3 Jonathan Shamash MBChB, MD, MRCP of Barts and The London NHS Trust speaks about The impact of a supranetwork multidisciplinary…
Molecular aging and p16INK4a in testicular cancer survivors Testicular 1 Min Read3 Maria Teresa Bourlon, MD, MS, of Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, discusses the…
TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: Highlights in GU Oncology from ASCO 2018 (BMIC-061) Testicular 1 Min Read2 Dr. Dan Goldstein reviews results of a trial of chemo regimen TIP (paclitaxel, ifosfamide, cisplatin) vs BEP (bleomycin, etoposide, cisplatin)…
